Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587127 · ClinicalTrials.gov registry record · NA
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
A NA study of Dyspepsia and Functional Dyspepsia, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05587127 is a NA study of Dyspepsia and Functional Dyspepsia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 72-participant average among 11 other Dyspepsia trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05587127, a NA study of Dyspepsia and Functional Dyspepsia, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized controlled trial of an exposure-based behavioral treatment (CBT) in adults with functional dyspepsia who meet criteria for avoidant/restrictive food intake disorder (ARFID) with weight loss.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-11-30 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05587127
The ClinicalTrials.gov registry entry for NCT05587127 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 72-participant average among 11 other Dyspepsia trials with a reported enrollment target (31% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Dyspepsia appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.
NCT05587127 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05587127 about?
NCT05587127 is a clinical study titled "Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia". Randomized controlled trial of an exposure-based behavioral treatment (CBT) in adults with functional dyspepsia who meet criteria for avoidant/restrictive food intake disorder (ARFID) with weight loss.
What is the current status of trial NCT05587127?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-11-30. Estimated completion is 2027-05.
What conditions does trial NCT05587127 study?
This clinical trial studies the following conditions: Dyspepsia, Functional Dyspepsia, Cognitive Behavioral Therapy, Feeding and Eating Disorders, Avoidant/Restrictive Food Intake Disorder.
What interventions are being tested in trial NCT05587127?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05587127?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05587127 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspepsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Visible Abdominal Distension
RECRUITING · NA
-
Zypan Functional Dyspepsia
RECRUITING · NA
-
High Resolution Gastric Mapping and Gastroduodenal Manometry
RECRUITING · NA
-
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
RECRUITING · NA
-
Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility
ACTIVE NOT RECRUITING · NA
-
Melatonin in Pediatric FD Population
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.